{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:55:30Z","timestamp":1773111330458,"version":"3.50.1"},"reference-count":86,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1586\/14737175.2014.915741","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T07:21:36Z","timestamp":1398842496000},"page":"593-605","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder"],"prefix":"10.1586","volume":"14","author":[{"given":"Cecilio","family":"\u00c1lamo","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences (Pharmacology Area), Faculty of Medicine and Health Sciences, University of Alcal\u00e1,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"L\u00f3pez-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences (Pharmacology Area), Faculty of Medicine and Health Sciences, University of Alcal\u00e1,","place":["Spain"]},{"name":"Faculty of Health Sciences, Camilo Jos\u00e9 Cela University,","place":["Spain"]},{"name":"\u2018Hospital 12 de Octubre\u2019 Research Institute,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences (Pharmacology Area), Faculty of Medicine and Health Sciences, University of Alcal\u00e1,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.3.261"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jad.2007.08.007","article-title":"Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission","volume":"107","author":"Vieta E","year":"2008","unstructured":"Vieta E, Sanchez-Moreno J, Lahuerta J, Zaragoza S; EDHIPO Group (Hypomania Detection Study Group). Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. J Affect Disord 2008;107:169-74","journal-title":"J Affect Disord"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125311420752"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.02.006"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2008.00604.x"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1109"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0910"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0073-y"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00711.x"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/10673221003747955"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00467.x"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00786.x"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.12.7"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070984"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00355-X"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2012.00991.x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S51910"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1014"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102919"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00672.x"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622970903555881"},{"key":"e_1_3_3_27_1","volume-title":"Guia sobre el maneig del trastorn bipolar a Catalunya. Agencia d\u2019Informaci\u00f3","author":"Vieta E","year":"2011","unstructured":"Vieta E, Murru A, Pueyo MJ. Guia sobre el maneig del trastorn bipolar a Catalunya. Agencia d\u2019Informaci\u00f3. Avaluacio i Qualitat en Salut. Servei Catala de la Salut; Barcelona, Spain: 2011"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04995gre"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.2.217"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12027"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2007.58.1.85"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04301"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor MM","year":"2010","unstructured":"Sidor MM, MacQueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry 2010;72:156-67","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3410\/M2-47","article-title":"Pharmaceutical treatment of acute bipolar depression","volume":"2","author":"Fountoulakis KN","year":"2010","unstructured":"Fountoulakis KN. Pharmaceutical treatment of acute bipolar depression. F1000 Med Rep 2010;2:47-51","journal-title":"F1000 Med Rep"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.095349"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01257.x"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01514.x"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.232"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1537"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.01.004"},{"key":"e_1_3_3_41_1","volume-title":"Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care","author":"NICE Clinical Guidelines","year":"2009","unstructured":"NICE Clinical Guidelines. Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Institute for Health and Clinical Excellence; London, UK: 2009"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.10.033"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000491"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.1.29"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2005.06.002"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2008.10.012","article-title":"EA: Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial","volume":"33","author":"Juruena MF","year":"2009","unstructured":"Juruena MF, Ottoni GL, Machado-Vieira R, et al. EA: Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:94-9","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0253-7176.85390","article-title":"Management of Bipolar Depression","volume":"33","author":"Chang JS","year":"2011","unstructured":"Chang JS, Ha K. Management of Bipolar Depression. Indian J Psychol Med 2011;33:11-17","journal-title":"Indian J Psychol Med"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048504"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00292.x"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04152"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.169"},{"key":"e_1_3_3_52_1","first-page":"114","article-title":"International scientific productivity on second-generation antipsychotic drugs in Taiwan: a bibliometric study","volume":"26","author":"L\u00f3pez-Mu\u00f1oz F","year":"2012","unstructured":"L\u00f3pez-Mu\u00f1oz F, Shen WW, Moreno R, et al. International scientific productivity on second-generation antipsychotic drugs in Taiwan: a bibliometric study. Taiwanese J Psychiatry 2012;26:114-29","journal-title":"Taiwanese J Psychiatry"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4236\/ojpsych.2013.31004","article-title":"Thirty years of scientific research on second-generation antipsychotic drugs in Japan: a bibliometric analysis","volume":"3","author":"L\u00f3pez-Mu\u00f1oz F","year":"2013","unstructured":"L\u00f3pez-Mu\u00f1oz F, Shinfuku N, Shen WW, et al. Thirty years of scientific research on second-generation antipsychotic drugs in Japan: a bibliometric analysis. Open J Psychiatry 2013;3:18-25","journal-title":"Open J Psychiatry"},{"key":"e_1_3_3_54_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4306\/pi.2013.10.1.8","article-title":"Trends in scientific literature on atypical antipsychotics in South Korea: a bibliometric study","volume":"10","author":"L\u00f3pez-Mu\u00f1oz F","year":"2013","unstructured":"L\u00f3pez-Mu\u00f1oz F, Shen WW, Pae CU, et al. Trends in scientific literature on atypical antipsychotics in South Korea: a bibliometric study. Psychiatry Investig 2013;10:8-16","journal-title":"Psychiatry Investig"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/1039856213492352"},{"key":"e_1_3_3_56_1","first-page":"349","article-title":"Mapping the scientific research on atypical antipsychotic drugs in Spain: a bibliometric assessment","volume":"41","author":"L\u00f3pez-Mu\u00f1oz F","year":"2013","unstructured":"L\u00f3pez-Mu\u00f1oz F, Rubio G, Molina JD, et al. Mapping the scientific research on atypical antipsychotic drugs in Spain: a bibliometric assessment. Actas Esp Psiquiatr 2013;41:349-60","journal-title":"Actas Esp Psiquiatr"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713001168"},{"key":"e_1_3_3_58_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1461145709990344","article-title":"Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis","volume":"13","author":"Cruz N","year":"2013","unstructured":"Cruz N, Sanchez-Moreno J, Torres F, et al. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol 2013;13:5-14","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111408461"},{"issue":"1","key":"e_1_3_3_60_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852913000746","article-title":"A review of FDA-approved treatment options in bipolar depression","volume":"18","author":"McIntyre RS","year":"2013","unstructured":"McIntyre RS, Cha DS, Kim RD, Mansur RB. A review of FDA-approved treatment options in bipolar depression. CNS Spectr 2013;18(Suppl 1):1-21","journal-title":"CNS Spectr"},{"issue":"1","key":"e_1_3_3_61_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1888-9891(12)70012-5","article-title":"Eficacia de quetiapina de liberaci\u00f3n prolongada en la sintomatolog\u00eda afectiva","volume":"5","author":"\u00c1lamo C","year":"2012","unstructured":"\u00c1lamo C, Lopez-Mu\u00f1oz F. Eficacia de quetiapina de liberaci\u00f3n prolongada en la sintomatolog\u00eda afectiva. Rev Psiquiatr Salud Ment (Barc) 2012;5(Suppl 1):3-19","journal-title":"Rev Psiquiatr Salud Ment (Barc)"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.11.1079"},{"issue":"5","key":"e_1_3_3_63_1","doi-asserted-by":"crossref","first-page":"o1357","DOI":"10.1107\/S1600536812012883","article-title":"Lurasidone hydro-chloride","volume":"68","author":"Zhang H","year":"2012","unstructured":"Zhang H, Wang H, Zhu X, et al. Lurasidone hydro-chloride. Acta Crystallogr Sect E Struct Rep Online 2012;68(Pt. 5):o1357","journal-title":"Acta Crystallogr Sect E Struct Rep Online"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.167346"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3103-z"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2247-y"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S18059"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2004.04.026"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2007.08.012"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.05.012"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.04.017"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707005"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.106047"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/1359786806066040"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300027"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.180638"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105058378"},{"issue":"1","key":"e_1_3_3_78_1","first-page":"395","article-title":"Lurasidone pharmacokinetics: assessment of potential for drug\u2013drug interactions","volume":"35","author":"Preskorn S","year":"2010","unstructured":"Preskorn S, Chiu YY, Sarubbi D, et al. Lurasidone pharmacokinetics: assessment of potential for drug\u2013drug interactions. Neuropsychopharmacology 2010;35(Suppl 1):395","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.575061"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903286388"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.3371\/CSRP.4.4.5"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2011.579"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.10.040"},{"key":"e_1_3_3_84_1","first-page":"1","article-title":"A Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study","volume":"16","author":"Citrome L","year":"2013","unstructured":"Citrome L, Weiden PJ, McEvoy JP, et al. A Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study. CNS Spectr 2013;16:1-10","journal-title":"CNS Spectr"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.057612"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05934"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070985"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31825ccde5"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12025"},{"key":"e_1_3_3_90_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.2013.13091240","article-title":"Lurasidone and Bipolar Disorder","volume":"171","author":"Belmaker RH","year":"2014","unstructured":"Belmaker RH. Lurasidone and Bipolar Disorder. Am J Psychiatry 2014;171:131-3","journal-title":"Am J Psychiatry"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737175.2014.915741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:27:30Z","timestamp":1772746050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737175.2014.915741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1586\/14737175.2014.915741"],"URL":"https:\/\/doi.org\/10.1586\/14737175.2014.915741","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}